Despite the COVID-19 outbreak, patient enrollment in the Phase 2 trial of setanaxib, an investigational oral treatment for idiopathic pulmonary…
Articles by Joana Carvalho, PhD
Men with idiopathic pulmonary fibrosis (IPF) are at higher risk of death and are more likely to require a…
A person’s sex appears to affect whether or not they are diagnosed with idiopathic pulmonary fibrosis (IPF), according to a study…
High levels of the protein osteopontin in the blood are associated with acute exacerbations and a higher risk of…
Algernon Pharmaceuticals‘s NP-120 (ifenprodil) outperformed Merck‘s MK-7264 (gefapixant) in an animal model of acute cough, a preclinical study by…
Treatment with Esbriet (pirfenidone) before and after cancer removal surgery reduces the risks of acute flares following…
UCLA Health has launched a $20-million fundraising initiative to support the creation of a new research and treatment center…
Chronic viral infections caused by the Epstein-Barr virus (EBV), cytomegalovirus (CMV), human herpesvirus 7 (HHV7), and…
Indalo Therapeutics announced that dosing has begun in the first patient enrolled in its Phase 1 trial assessing the…
A positron emission tomography (PET) tracer that recognizes a potential protein biomarker of fibrotic interstitial lung diseases can be used…